Oxford Biomedica and Institut Merieux enter into exclusive negotiations with respect to the proposed acquisition by Oxford Biomedica of ABL Europe from Institut Merieux as part of pure-play CDMO transformation
Oxford - Oxford Biomedica plc , a quality and innovation-led cell and gene therapy CDMO, and Institut Merieux SA today announce that they have entered into exclusive negotiations with respect to the...
United Kingdom Oxford Biomedica Frank Mathias Sophia Bolhassan Institut Merieux Merieux Nutrisciences
Source: marketscreener.com